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Studies from the US have shown variations in breast cancer incidence, stage distribution, treatment and survival between ethnic
groups. Data on 35631 women diagnosed with breast cancer in South East England between 1998 and 2003 with self-assigned
ethnicity information available were analysed. Results are reported for White, Indian, Pakistani, Bangladeshi, Black Caribbean, Black
African and Chinese women. Age-standardised breast cancer incidence rate ratios, patterns of stage of disease at diagnosis,
treatment, overall and breast cancer-specific survival were examined. All ethnic groups studied had lower age-standardised breast
cancer incidence rates than White women, with Bangladeshi women having the lowest rate ratio (0.23, 95% CI: 0.20–0.26). White
women were the most likely to have a stage recorded at diagnosis (adjusted proportion 75%), and least likely to be diagnosed with
metastatic disease (7%). Black African women were the least likely to have a record of cancer surgery (63%) or hormone therapy
(32%), and most likely to receive chemotherapy (38%). After fully adjusting for age, socioeconomic deprivation, stage of disease and
treatment received, there was no significant variation in breast cancer-specific survival. However, Black African women had
significantly worse overall survival (hazard ratio 1.24, P¼0.025). These findings suggest that a strategy of earlier detection should be
pursued in Black and South Asian women.
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Data from the United States show a lower breast cancer incidence
in Black than White women, (Ward et al, 2004; Smigal et al, 2006)
even after adjusting for socioeconomic status (Chlebowski et al,
2005). Using country of birth and names to assign ethnicity, a
significantly lower incidence has been found in South Asian than
in non-South Asian women (Winter et al, 1999; Smith et al, 2003),
and in women born in the ‘Caribbean Commonwealth’ and South
Asia than in the general female population in England and Wales
(Harding and Rosato, 1999).
Many comparisons of stage of disease at diagnosis and
treatment of cancer patients by ethnic group have been made in
the United States. Whereas Black (Li et al, 2003; Morris et al, 2007)
and Indian/Pakistani women (Li et al, 2003) were more likely to
have advanced stage disease than White women, Hahn et al (2007)
found no association between ethnicity and advanced stage after
adjustment for several factors. Black women in the US also appear
less likely to receive systemic chemotherapy and hormone therapy
(Naeim et al, 2006) and more likely to receive inappropriate
treatment compared to national guidelines (Li et al, 2003) than
White women. US studies have shown that Black women have a
lower survival (Grann et al, 2006; Smigal et al, 2006), Chinese
women have a better survival, and there is no difference between
Indian/Pakistani women’s survival compared with White women
(Li et al, 2003).
The area of South East England covered by the Thames Cancer
Registry (TCR) is the most ethnically diverse in England, including
groups who are from low incidence areas of the world. Hospital
Episode Statistics (HES) data are available for all inpatient
admissions to English NHS hospitals and include self-assigned
ethnicity, which is more complete than that in TCR (Jack et al,
2006). This study used all available ethnicity data to describe
patterns of breast cancer incidence, stage, treatment and survival
in different ethnic groups in South East England.
MATERIALS AND METHODS
In the United Kingdom, cancer registries record the occurrence of
cancer in their resident populations. In the area covered by the
TCR, registration is initiated by clinical and pathological informa-
tion received from hospitals and by information about deaths
provided by the National Health Service Central Register through
the Office for National Statistics. Trained data collection officers
then extract further information on demographic details, disease
stage and treatment in the first 6 months after diagnosis from the
medical records. TCR uses a simple four-level staging system,
using information in the patients’ notes. This allows solid tumours
to be assigned to categories based on whether the disease is local,
has direct extension beyond the organ of origin, has regional
lymph node involvement, or has metastasised. Data are quality
assured as they are added to the central database. Hospital Episode
Statistics data come from hospital Patient Administration Systems
and include patient, clinical, administrative and geographical
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April 1995 using the codes from the England and Wales 1991 Census.
In April 2001 the new 2001 Census ethnic codes were brought in,
although the 1991 codes were still accepted until March 2003.
Records on 55710 women diagnosed with breast cancer (ICD-10
code C50) between 1998 and 2003 were extracted from the TCR
database. Hospital Episode Statistics data on all patients residing
in South East England with cancer (or suspected cancer) admitted
to NHS hospitals between April 1997 and March 2004 were
obtained. These patient records were matched to the TCR records
using either NHS number, or sex, date of birth and postcode. The
ethnicity code was extracted from HES and added to the TCR
record. If there was no match, and an ethnic code was available
from TCR records, this was used.
Ethnic groups were classified into the following categories:
White, Mixed, Indian, Pakistani, Bangladeshi, Asian Other, Black
Caribbean, Black African, Black Other, Chinese, Other or Not
Known. Although analyses were performed using all available
information, results are only presented for the seven groups that
are easily combined from the 1991 and 2001 Censuses: White,
Indian, Pakistani, Bangladeshi, Black Caribbean, Black African and
Chinese. Socioeconomic deprivation was measured using the
income domain of the Index of Multiple Deprivation 2000
(Department of the Environment, Transport and the Regions,
2000), divided into quintiles across England and Wales and
assigned to records using postcode of residence at diagnosis.
It was not possible to determine an ethnic code for all patients.
As there is no ‘ethnicity not known’ group in the population data
based on the census, the absolute values of computed age-
standardised incidence rates by ethnic group are too low due to the
exclusion of the patients without a valid ethnic code. To address
this, age-standardised rate ratios were calculated, using Census
2001 data as the population denominator, with White women as
the baseline group. Confidence intervals were calculated using the
method described in Boyle and Parkin (1991). These were also
calculated separately for three truncated age groups: under 50,
50–64 and 65 years and older.
Patients who are registered by death certificate only have limited
information recorded in the TCR database. These patients are
included in the incidence analyses, but excluded from analyses on
stage, treatment and mortality. There were 2117 (3.8%) cases
registered by death certificate only in this dataset. Logistic regression
was performed to analyse the availability of the patients’ stage at
diagnosis. If stage was recorded, logistic regression was again used to
determine whether the patient was diagnosed with metastatic
disease. Results from both analyses were transformed to generate
proportions adjusted for age and socioeconomic deprivation. The
proportions of each ethnic group receiving non-investigative cancer
surgery, radiotherapy, chemotherapy, and hormone therapy within
the first 6 months of diagnosis were calculated. Using logistic
regression these proportions were adjusted for age at diagnosis,
socioeconomic deprivation and stage at diagnosis.
Survival was analysed using Cox regression, with patients
followed up until 31 December 2006. Deaths from all causes and
from breast cancer were analysed separately. A death was
considered to have been due to breast cancer if the ICD-10 code
C50, ICD-9 code 174 or the word ‘breast’ were included in Part 1 of
the death certificate. The estimated hazard ratios (HR) were
sequentially adjusted for age, socioeconomic deprivation, stage at
diagnosis and treatment received.
RESULTS
Ethnicity information was available for 35631 (64%) of the 55710
records of women diagnosed with breast cancer extracted from the
database. Excluding cases registered by death certificate only,
34998 (65%) of 53593 patients had a known ethnicity. Incidence
results are reported for the seven ethnic groups, which make up
60% (33633) of the total cases. In all 33024 (62%) cases had
complete registration information rather than incomplete infor-
mation from a death certificate only and the results for stage,
treatment and survival analyses are shown for this group.
White women had the highest age-standardised breast cancer
incidence rates. Incidence rate ratios were calculated with White
women as the baseline group, and were all significantly below one:
Indian (0.68; 95% CI, 0.64–0.73), Pakistani (0.59; 95% CI,
0.51–0.69), Bangladeshi (0.23; 95% CI, 0.20–0.26), Black
Caribbean (0.80; 95% CI, 0.74–0.86), Black African (0.66; 95%
CI, 0.59–0.74) and Chinese (0.54; 95% CI, 0.47–0.63).
Figure 1 shows age-standardised incidence rate ratios calculated
separately for different age groups. Younger women of different
ethnic groups had incidence rates more similar to White women of
the same age. This pattern was evident in Bangladeshi, Black
Caribbean, Black African and Chinese women, but was less clear
for Pakistani women. There was no difference in the incidence rate
ratios for the different age groups of Indian women.
Results of the analyses of stage, adjusted for age and socio-
economic deprivation, are shown in Table 1. White women were
most likely to have a stage recorded at diagnosis (75%), and
Bangladeshi women were least likely (55%). After excluding
patients with stage not known, Pakistani women were most likely
to be diagnosed with metastatic disease (17%) and White women
the least likely (7%). White women were less likely to be diagnosed
with metastatic disease than all other groups, although the
difference was not significant for Bangladeshi and Chinese women
due to small numbers.
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Figure 1 Age-standardised breast cancer incidence rate ratios (ASRR)
and 95% confidence intervals by age group with White women as the
baseline group.
Table 1 Percentage of breast cancer patients having a stage recorded at
diagnosis, and of staged patients, those with metastatic disease at diagnosis
by ethnic group, adjusted for age and socioeconomic deprivation
Staged Metastatic disease
Total n % P-value n % P-value
White 31109 23271 75 1743 7
Indian 639 446 67 o0.001 43 11 0.012
Pakistani 121 86 69 0.128 13 17 0.003
Bangladeshi 42 25 55 0.007 3 13 0.297
Black Caribbean 652 493 73 0.270 57 11 0.003
Black African 344 253 71 0.082 36 15 o0.001
Chinese 117 85 71 0.388 7 10 0.435
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different treatments, adjusted for age, socioeconomic deprivation
and stage. The largest differences were seen between White and
Black African women. Black African women were less likely to
have a record of cancer surgery (63 vs 72%, P¼0.003) and
hormone therapy (32 vs 54%, Po0.001), and more likely to receive
chemotherapy (38 vs 29%, P¼0.001) than White women. Pakistani
women were significantly less likely to receive radiotherapy (27 vs
36%, P¼0.043) and hormone therapy (41 vs 54%, P¼0.014) than
White women, whereas Black Caribbean women were less likely to
receive hormone therapy (39 vs 54%, Po0.001). Several other
associations were of borderline significance, or not significant
because of the small numbers. Bangladeshi (41%, P¼0.179),
Chinese (47%, P¼0.191) and Indian (50%, P¼0.074) women were
less likely to receive hormone therapy than White women (54%);
Chinese (28 vs 36%, P¼0.088) and Black Caribbean (32 vs 36%,
P¼0.078) were less likely to receive radiotherapy, and Chinese
women were also more likely to receive surgery (79 vs 72%,
P¼0.148).
The patterns of survival using death from any cause are shown
in Table 3, sequentially adjusted for age, socioeconomic depriva-
tion, stage and treatment. Chinese women had a lower risk of
dying than White women, which was largely unaffected by
adjustment (fully adjusted HR¼0.66, P¼0.088). All other ethnic
groups had higher risks of dying compared with White women
after adjustment for age only. However, only Black African
women’s risk of dying remained high after additional adjustment
for socioeconomic deprivation and stage (HR¼1.42, Po0.001),
and although attenuated, was still high after further adjustment for
treatment (HR¼1.24, P¼0.025). Women living in the most
socioeconomically deprived area had the worst overall survival
(HR 1.25, Po0.001).
Results for breast cancer-specific survival, again adjusted for
age, socioeconomic deprivation, stage and treatment, are shown
in Table 4. There was a similar pattern to the overall survival:
Chinese women had the lowest risk of dying from breast cancer
(fully adjusted HR¼0.63, P¼0.089) and Black African women
had the highest (fully adjusted HR¼1.09, P¼0.412). The
worse breast cancer-specific survival in the other groups was
attenuated by adjustment, and no significant association was
found after adjusting for age, socioeconomic deprivation, stage
and treatment.
DISCUSSION
This study found variations in breast cancer incidence, stage at
diagnosis and treatment received between different ethnic groups
Table 2 Percentage of breast cancer patients receiving different treatments by ethnic group, adjusted for age, socioeconomic deprivation and stage
Cancer surgery Radiotherapy Chemotherapy Hormone therapy
Total n % P-value n % P-value n % P-value n % P-value
White 31109 22421 72 11060 36 9006 29 16678 54
Indian 639 469 70 0.398 231 35 0.955 229 26 0.185 275 50 0.074
Pakistani 121 91 75 0.584 32 27 0.043 51 30 0.749 40 41 0.014
Bangladeshi 42 29 69 0.706 13 36 0.949 19 27 0.770 11 41 0.179
Black Caribbean 652 492 73 0.712 199 32 0.078 276 32 0.156 203 39 o0.001
Black African 344 234 63 0.003 100 33 0.390 205 38 0.001 70 32 o0.001
Chinese 117 95 79 0.148 31 28 0.088 58 30 0.834 43 47 0.191
Table 3 Hazard ratios for all cause mortality in breast cancer patients diagnosed 1998–2003
Adjusted for age Socioeconomic deprivation Stage Treatment
HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value HR 95% CI P-value
Ethnic group
White 1.00 1.00 1.00 1.00
Indian 1.10 0.93 1.29 0.256 1.05 0.89 1.23 0.590 0.92 0.78 1.08 0.299 0.91 0.78 1.08 0.285
Pakistani 1.22 0.85 1.76 0.278 1.14 0.79 1.64 0.493 0.95 0.66 1.36 0.766 0.92 0.64 1.33 0.665
Bangladeshi 1.08 0.56 2.08 0.818 0.99 0.51 1.90 0.972 0.76 0.39 1.46 0.406 0.88 0.46 1.69 0.695
Black Caribbean 1.23 1.06 1.43 0.006 1.11 0.96 1.29 0.157 1.01 0.87 1.18 0.864 0.98 0.85 1.14 0.811
Black African 1.83 1.51 2.21 o0.001 1.64 1.36 1.99 o0.001 1.42 1.18 1.72 o0.001 1.24 1.03 1.50 0.025
Chinese 0.69 0.43 1.11 0.123 0.67 0.42 1.08 0.104 0.66 0.41 1.07 0.089 0.66 0.41 1.06 0.088
Test for heterogeneity:
w
2 (6 d.f.)
50.5 Po0.0001 31.5 Po0.0001 18.4 P¼0.0053 9.7 P¼0.1383
Socioeconomic deprivation
1 (most affluent) 1.00 1.00 1.00
2 1.06 1.01 1.11 0.027 1.09 1.04 1.15 o0.001 1.10 1.04 1.15 o0.001
3 1.17 1.11 1.23 o0.001 1.19 1.13 1.25 o0.001 1.19 1.13 1.25 o0.001
4 1.22 1.16 1.28 o0.001 1.25 1.19 1.31 o0.001 1.24 1.18 1.30 o0.001
5 (most deprived) 1.36 1.29 1.43 o0.001 1.27 1.21 1.34 o0.001 1.25 1.19 1.32 o0.001
Test for trend: w
2 (1 d.f.) 169.9 Po0.0001 111.3 Po0.0001 96.9 Po0.0001
Treatment
Cancer surgery 0.49 0.48 0.51 o0.001
Radiotherapy 0.78 0.75 0.81 o0.001
Chemotherapy 1.53 1.46 1.60 o0.001
Hormone therapy 0.90 0.87 0.93 o0.001
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standardised incidence rates and Bangladeshi women the lowest.
The rates in younger women from different ethnic groups
appeared to be converging. White women were most likely to
have a stage recorded at diagnosis and least likely to present with
advanced stage disease. There was significant variation in the
treatment received by different ethnic groups, but these differences
were generally consistent with differences in the proportion of
patients with advanced disease.
There was less variation in survival between ethnic groups.
Chinese women had the best overall and breast cancer-specific
survival. Black African women had the worst overall survival, but
the effect was not as strong for breast cancer-specific survival.
Variation among other ethnic groups was explained by adjustment
for other variables. Although adjustment for stage and treatment
explained the variation in breast cancer-specific survival, it did not
explain the worse survival for women living in more deprived areas.
This study replicates previous findings that White women have
higher incidence rates than Black women in the United States
(Ward et al, 2004; Chlebowski et al, 2005; Smigal et al, 2006) and
the United Kingdom (Harding and Rosato, 1999). It also confirms
that South Asian women have lower incidence rates than White
women (Harding and Rosato, 1999; Winter et al, 1999; Smith et al,
2003), and is able to verify this separately for Indian, Pakistani and
Bangladeshi women.
Screening detects cancers which are asymptomatic and may not
have otherwise been diagnosed or recorded. There is evidence that
in the United Kingdom screening uptake is lower in women who
live in more deprived areas (Maheswaran et al, 2006) and that
White British people are less likely to live in the most deprived
areas of England (Tinsley and Jacobs, 2006). The analyses of
incidence in this study did not take deprivation into account and
therefore the higher incidence rates in White women could be
partly due to more screen-detected disease. Screening will also
affect the stage of disease, as it will detect less advanced tumours
before they become symptomatic. However, even after adjusting
for socioeconomic deprivation, the results of this study are
consistent with previous findings of more advanced disease at
diagnosis in Indian, Pakistani and Black women (Li et al, 2003;
Morris et al, 2007). Hahn et al (2007) found no difference in
disease stage at diagnosis between Black and White women after
adjustment for several factors, including age, level of education,
insurance status, poverty, method of detection and tumour
characteristics. It is possible that some of these factors would
explain the variation found in the present study.
In the United States, Black women are less likely to receive
chemotherapy and hormone therapy (Naeim et al, 2006). In our
study, Black Caribbean and Black African women were less likely
to receive hormone therapy, but the latter were more likely to
receive chemotherapy. This pattern of treatment in Black African
women may reflect differences in stage and triple-negative disease
(oestrogen receptor, progesterone receptor and human epidermal
growth factor receptor 2 (HER2) negative). Studies in the United
States have shown that Black women are more likely to have triple-
negative breast cancer than White women (Bauer et al, 2007;
Morris et al, 2007). This was also suggested by a study of patients
below age 60 in a hospital population in London, although this
result was not significant (Bowen et al, 2008). Triple-negative
disease does not respond to hormone therapy, and chemotherapy
may be the preferred treatment option for these cancers (Cleator
et al, 2007).
US Black women had worse survival than White women, even
after accounting for patient, tumour and geographical factors
(Li et al, 2003; Grann et al, 2006). Chinese women had better
survival than White women, and there was no significant
difference between Indian/Pakistani and White women after
adjusting for age, tumour characteristics and treatment (Li et al,
2003). An earlier study in the TCR area found women with South
Asian names had better relative survival than non-South Asian
women (dos Santos Silva et al, 2003). In a London hospital
population Black women with smaller tumours had significantly
worse overall survival than White women with similar sized
tumours, adjusting for age and socioeconomic deprivation (Bowen
et al 2008). In our study, Black African women had significantly
Table 4 Hazard ratios for breast cancer mortality (coded cause 1a, 1b or 1c mentioning ‘C50’ or ‘174’ or text cause 1a, 1b or 1c mentioning ‘breast’) in
breast cancer patients diagnosed 1998–2003
Adjusted for age Socioeconomic deprivation Stage Treatment
HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P
Ethnic group
White 1.00 1.00 1.00 1.00
Indian 1.08 0.89 1.30 0.437 1.02 0.85 1.23 0.809 0.86 0.71 1.03 0.105 0.86 0.71 1.04 0.118
Pakistani 1.19 0.79 1.80 0.400 1.11 0.74 1.67 0.625 0.87 0.58 1.31 0.496 0.87 0.58 1.31 0.501
Bangladeshi 1.25 0.65 2.40 0.507 1.13 0.59 2.18 0.711 0.85 0.44 1.63 0.618 1.00 0.52 1.93 0.990
Black Caribbean 1.31 1.11 1.55 0.001 1.18 1.00 1.39 0.054 1.03 0.87 1.21 0.748 1.01 0.85 1.19 0.953
Black African 1.74 1.42 2.14 o0.001 1.56 1.27 1.91 o0.001 1.27 1.03 1.56 0.025 1.09 0.89 1.34 0.412
Chinese 0.67 0.39 1.13 0.131 0.65 0.39 1.10 0.112 0.62 0.37 1.06 0.079 0.63 0.38 1.07 0.089
Test for heterogeneity:
w
2 (6 d.f.)
41.6 Po0.0001 23.8 P¼0.0006 11.8 P¼0.0657 6.5 P¼0.3679
Socioeconomic deprivation
1 (most affluent) 1.00 1.00 1.00
2 1.10 1.03 1.17 0.004 1.14 1.07 1.21 o0.001 1.13 1.07 1.21 o0.001
3 1.19 1.12 1.27 o0.001 1.21 1.14 1.29 o0.001 1.21 1.14 1.29 o0.001
4 1.24 1.16 1.32 o0.001 1.26 1.18 1.34 o0.001 1.25 1.17 1.33 o0.001
5 (most deprived) 1.41 1.33 1.51 o0.001 1.26 1.18 1.35 o0.001 1.27 1.19 1.35 o0.001
Test for trend: w
2 (1 d.f.) 124.7 Po0.0001 61.6 Po0.0001 62.0 Po0.0001
Treatment
Cancer surgery 0.47 0.45 0.49 o0.001
Radiotherapy 0.85 0.82 0.89 o0.001
Chemotherapy 1.76 1.67 1.85 o0.001
Hormone therapy 0.86 0.83 0.90 o0.001
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deprivation, stage at diagnosis and treatment, and Chinese women
had better survival, although not significantly so due to small
numbers. No significant variation in survival was found in Indian,
Pakistani or Bangladeshi women.
A significant limitation of this study is that ethnicity information
was not available for a large proportion (36%) of the patients. This
could potentially bias the results if particular ethnic groups were
over or underrepresented in the missing data. The computed
incidence rate ratios assume that the proportion of missing values
was the same in each of the different ethnic groups. All women
diagnosed, including those with unknown ethnicity, were included
in the analyses for stage, treatment and survival. Women with
unknown ethnicity had a lower risk of dying from all causes (fully
adjusted HR¼0.89, Po0.001) and from breast cancer (HR¼0.90,
Po0.001) than White women. A sensitivity analysis was performed
using the extreme assumption that all women of unknown ethnicity
were White. The results for the other ethnic groups compared with
this extended White group were very similar to the ones presented.
Black African women had a significantly high fully adjusted HR
when using all causes of death (HR¼1.29, P¼0.009), and although
their breast cancer-specific survival was also high, it was not
statistically significant (HR¼1.13, P¼0.252). All other ethnic
groups had non-significant HRs compared with the new group of
White women and women with unknown ethnicity. Improving
ethnicity data collection is a key target for routinely collected
datasets including hospital records, HES, and cancer registers.
Although this study was able to investigate ethnic groups at a
more detailed level than most previous studies, there could still be
important differences within these groups. For example, McCor-
mack et al (2004) examined groups defined by place of birth
(including area within country), first language and religion. The
associations between these groups and risk of breast cancer lost
their significance after adjustment for reproductive, socioeco-
nomic, anthropometric and dietary factors. These and other
factors such as comorbidity, which are not routinely recorded by
cancer registries could contribute to the differences in treatment
and survival. As the registry only collects information on treatment
received up to 6 months after diagnosis, some treatment data are
missing, although this is unlikely to vary by ethnic group.
The interpretation of survival differences between ethnic groups
must recognise the likelihood of strong associations between
socioeconomic factors, disease stage at diagnosis and treatment. In
the analysis of breast cancer-specific survival, there was a gradual
attenuation of the survival differences between ethnic groups as
more variables were adjusted for. The adjustment for socio-
economic deprivation, disease stage and treatment all tended to
work towards a reduction of the excess mortality in the South
Asian and Black groups. The most plausible interpretation is that
survival differences are principally due to variation in stage at
presentation, which in these data is manifest both through the
recorded stage at diagnosis, but also independently through the
recorded socioeconomic deprivation and the administered treat-
ment. It seems very unlikely that there are biologically based
differences between the ethnic groups, which confer strong
survival differences, independently of stage and treatment. The
only subanalysis that suggests this is the fully adjusted analysis of
overall survival in Black African women where the HR persisted at
a statistically significant value of 1.24. However, this estimate was
highly sensitive to adjustment for deprivation, stage and treatment,
which leaves room for an effect of residual confounding. Further,
the corresponding estimate in the breast cancer-specific analysis
was much lower at 1.09. Therefore, the present data suggest that
breast cancer services may usefully pursue a strategy of earlier
detection with the aim of achieving a more favourable stage
distribution at diagnosis. This should be a particular priority for
the South Asian and Black groups analysed here.
To determine more robustly whether biological, behavioural or
clinical factors are driving the observed differences, more
information is needed on patient characteristics. The most
important component is disease stage at diagnosis, as this will
affect both the treatment received and survival. Improving the
completeness of staging information as well as ethnicity informa-
tion received by cancer registries will enhance future analyses.
More advanced stage at diagnosis could reflect a more aggressive
form of disease, later presentation because of a lack of awareness
about symptoms or a mistrust of the health system, lower uptake
of screening or delays in diagnosis. There is evidence that different
ethnic groups have different ideas about causes of and candidacy
for breast cancer (Pfeffer, 2004), which may affect attitudes
towards accessing healthcare services. A better understanding of
these beliefs would therefore be important to guide a strategy for
earlier detection. Studies in the United States have also shown that
Black women are more likely to have high risk tumour
characteristics (Elledge et al, 1994) that are associated with earlier
death from breast cancer (Anderson et al, 2005). Earlier detection
is likely to be particularly important for these patients.
Although there are differences in recorded stage of disease at
diagnosis and treatment between ethnic groups, it is encouraging
that there is little variation in survival after adjustment for these
factors, suggesting that some of the survival differences found in
previous US studies (Grann et al, 2006; Smigal et al, 2006) may
reflect the problems some groups have in accessing effective
treatments in US healthcare systems. With better access to earlier
detection, and the possibility of more aggressive treatment,
survival could be improved for all women.
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